Delayed Börse Stuttgart 08:17:04 05/08/2026 pm IST 5-day change 1st Jan Change
0.003000 EUR 0.00% Intraday chart for MagForce AG 0.00% +50.00%
Current year+50.00%
3 months-14.29%
Current year+50.00%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.003
0.01
Current year 0
Extreme 0.001
0.02
1 year 0
Extreme 0.001
0.02
3 years 0
Extreme 0.0002
0.02
5 years 0
Extreme 0.0002
0.02
10 years 0
Extreme 0.0002
0.02
Manager TitleAgeSince
Chief Executive Officer 86 01/09/2013
Director of Finance/CFO 55 01/10/2012
Director TitleAgeSince
Chairman 54 12/08/2021
Director/Board Member 45 -
Director/Board Member 54 -
Date Insider Type Main position Quantity % Market Cap.
16/12/20 Buy

Chief Executive Officer

2,50,000 0.9045%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-25.00%+50.00% 1L
+0.32%-2.85%+0.14%+13.91% 4.8TCr
+0.89%+7.20%+405.22%+554.37% 4.11TCr
+3.09%-4.79%+28.15%+7.48% 3.76TCr
+2.20%+0.78%+7.34%+75.86% 3.59TCr
+2.42%+7.27%+14.90%+44.79% 2.99TCr
+0.76%-2.71% - - 1.61TCr
+1.86%+0.12%+34.22%+124.90% 1.61TCr
+1.25%+1.69%+4.80%+18.87% 1.38TCr
+4.43%-7.89%-1.12%-34.76% 1.21TCr
Average +1.84%-5.26%+52.07%+95.05% 2.5TCr
Weighted average by Cap. +1.85%-1.29%+81.24%+126.53%

Financials

2020 2021
Net sales 15.02L 17.3L 14.01L 12.87L 24.34L 16Cr 24.6L 1.65Cr 64.56L 8.23Cr 64.97L 63.55L 27Cr 10.77L 12.41L 10.04L 9L 17.45L 12Cr 17.64L 1.18Cr 46.29L 5.9Cr 46.58L 45.56L 20Cr
Net income 1.47Cr 1.7Cr 1.37Cr 1.26Cr 2.39Cr 161.55Cr 2.42Cr 16Cr 6.34Cr 81Cr 6.38Cr 6.24Cr 267.58Cr -1.06Cr -1.22Cr -98.59L -90.57L -1.71Cr -115.84Cr -1.73Cr -12Cr -4.54Cr -58Cr -4.57Cr -4.47Cr -191.87Cr
Net Debt - -
Logo MagForce AG
Magforce AG is a Germany-based company engaged in the provision of nanotechnology solutions for health sector. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The Company's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.
Employees
33
Date Price Change Volume
05/26/05 0.003000 0.00% 0
04/26/04 €0.003000 0.00% 215
03/26/03 €0.003000 0.00% 2,545
31/26/31 €0.003000 0.00% 0
30/26/30 €0.003000 0.00% 0